Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 101 ~ 120 of 26020, Page 6 of 1301
101. Explore Your Family Cancer History - 06/13/2019
 American Cancer Society
  Protect your health by learning more about your familys history of cancer and other health problems. Then find out what you can do to help lower your risk. Get the tips.
102. New Survey Shows Millennials Can Help Avoid Blood Shortages - 06/13/2019
 Abbott
  45% of blood donations have historically come from people over 50 years old, but that number is declining / As more millennials bring their passion to blood donation, they can fill the gap left by aging baby boomers
103. FDA Approves Polivy (Polatuzumab Vedotin-piiq) for Lymphoma - 06/12/2019
 American Cancer Society
  The US Food and Drug Administration (FDA) has approved the antibody-drug conjugate Polivy (polatuzumab vedotin-piiq) to treat people with diffuse large B-cell lymphoma (DLBCL).
104. AAOS Member Michael Suk, MD, Elected to AMA Board of Trustees - 06/12/2019
 American Academy of Orthopaedic Surgeons
105. Population of US Cancer Survivors Grows to Nearly 17 Million - 06/11/2019
 American Cancer Society
  A new report by the American Cancer Society ? in collaboration with the National Cancer Institute ? estimates there are more than 16.9 million cancer survivors alive in the US today, and that number will grow to more than 22.1 million by 2030.
106. FDA Approves Two New Indications for Mercks KEYTRUDA (pembrolizumab) - 06/11/2019
 MERCK
  KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma as Monotherapy for Patients Whose Tumors Express PD-L1 (CPS 1) or in Combination with Platinum and Fluorouracil (FU) Regardless of PD-L1 Expression
107. New Survey Highlights Growing Insurance Problem That Delays Sight-Saving Care - 06/11/2019
 American Academy of Ophthalmology
  Real-world data shows why new legislation introduced last week is needed to protect patients from unreasonable Medicare Advantage plan requirements
108. Collaboration between France and WHO to Realize the Vision of the WHO Academy - 06/11/2019
 WHO
109. Orthopaedic PAC Endorses AAOS Member Manny Sethi, MD, for U.S. Senate - 06/11/2019
 American Academy of Orthopaedic Surgeons
110. Mental and Physical Health Drive Employee Productivity - 06/10/2019
 American College of Occupational and Environmental Medicine (ACOEM)
  Mental and physical health are the most important factors affecting workplace productivity, reports an open-access paper in the June Journal of Occupational and Environmental Medicine.
111. Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes - 06/10/2019
 Medtronic
  ugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
112. Merck to Acquire Tilos Therapeutics - 06/10/2019
 MERCK
  Merck Gains Portfolio of Investigational Antibodies Modulating TGF
113. Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ - 06/10/2019
 Medtronic
  Four Year Partnership Made Public Today
114. Cancer Screening Rates Linked to Time of Medical Appointment - 05/17/2019
 American Cancer Society
  Researchers from the University of Pennsylvania say when patients see their doctor may affect whether they are told to get screened for cancer, and the likelihood of patients to have them done.
115. Too many babies are born too small - 05/16/2019
 WHO
  Around one in seven of all babies worldwide are born with a low birthweight
116. Merck to Present New Analyses for JANUVIA (sitagliptin) and STEGLATRO (ertugliflozin), and Real-World Data Studies at the 79th Scientific Sessions of the American Diabetes Association - 05/16/2019
 MERCK
  Real-World Evidence Research to Explore Socioeconomic, Racial and Ethnic Disparities in Diabetes Treatment
117. Do These Seven Things Today, to Save Your Sight Tomorrow - 05/16/2019
 American Academy of Ophthalmology
  The American Academy of Ophthalmology urges young adults to protect their eyes to prevent vision loss in the future
118. New ZonePerfect Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results - 05/16/2019
 Abbott
  Abbott's ZonePerfect Keto shakes and powders are formulated with a science-based macronutrient ("macros") ratio of 75% fat, 20% protein and 5% carbohydrates to support ketosis and burn body fat / ZonePerfect Keto helps fulfill a keto lifestyle on the go - offering the only true keto ready-to-drink option available nationwide at major retailers
119. Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases - 05/16/2019
 Medtronic
  FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons
120. New Research from Mercks Broad Oncology Clinical Development Program to be Presented at 2019 ASCO Annual Meeting - 05/15/2019
 MERCK
  First-Time Data from POLO Trial Evaluating LYNPARZA (olaparib) in Germline BRCA-Mutated Metastatic Pancreatic Cancer in Plenary Session and ASCO Press Program / KEYTRUDA (pembrolizumab) Five-Year Survival Data in Advanced Non-Small Cell Lung Cancer (NSCLC) from KEYNOTE-001 Trial in ASCO Press Program / Overall Survival Data for KEYTRUDA in Metastatic Renal Cell Carcinoma (RCC), Recurrent/Metastatic Head and Neck Cancer and Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer
<<  <  [1]  [2]  [3]  [4]  [5]  [6[7]  [8]  [9]  [10]  >  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com